OBJECTIVES: Coronary heart disease (CHD) is the most common cause of mortality and morbidity world-wide. Evidence on ethnic differences between the Roma and non-Roma regarding medical risk factors is scarce. The aim of this study was to assess differences in medical risk factors and the severity of CHD in Roma compared with non-Roma CHD patients, adjusted for gender, age and education. METHODS: Six hundred seventy four patients were included in this cross-sectional study (132 Roma, 542 non-Roma). Data on medical risk factors, symptoms, medication and severity of CHD were obtained from medical records. After matching Roma and non-Roma according to education, linear and logistic regression analyses with adjustments for gender and age were used. RESULTS: Compared with non-Roma, Roma patients had significantly more risk factors and more severe types of CHD. They were treated less frequently with statins and beta-blockers, were more frequently left on pharmacotherapy and surgically revascularised. These differences remained after controlling for education, gender and age. CONCLUSIONS: Roma CHD patients have a worse risk profile at entry of care and seem to be undertreated compared with non-Roma CHD patients.
OBJECTIVES:Coronary heart disease (CHD) is the most common cause of mortality and morbidity world-wide. Evidence on ethnic differences between the Roma and non-Roma regarding medical risk factors is scarce. The aim of this study was to assess differences in medical risk factors and the severity of CHD in Roma compared with non-Roma CHDpatients, adjusted for gender, age and education. METHODS: Six hundred seventy four patients were included in this cross-sectional study (132 Roma, 542 non-Roma). Data on medical risk factors, symptoms, medication and severity of CHD were obtained from medical records. After matching Roma and non-Roma according to education, linear and logistic regression analyses with adjustments for gender and age were used. RESULTS: Compared with non-Roma, Romapatients had significantly more risk factors and more severe types of CHD. They were treated less frequently with statins and beta-blockers, were more frequently left on pharmacotherapy and surgically revascularised. These differences remained after controlling for education, gender and age. CONCLUSIONS: Roma CHD patients have a worse risk profile at entry of care and seem to be undertreated compared with non-Roma CHDpatients.
Authors: Ahmad Bahonar; Nizal Sarrafzadegan; Roya Kelishadi; Shahin Shirani; Mohammad Arash Ramezani; Mohammad Hossein Taghdisi; Mojgan Gharipour Journal: Int J Public Health Date: 2010-02-12 Impact factor: 3.380
Authors: Lluís Cirera; José María Huerta; María Dolores Chirlaque; Genevieve Buckland; Nerea Larrañaga; María José Sánchez; Antonio Agudo; Pilar Amiano; José Ramón Quirós; Eva Ardanaz; Larraitz Arriola; Esther Molina; Miren Dorronsoro; Aurelio Barricarte; Carlos A González; Concepción Moreno-Iribas; Carmen Navarro Journal: Int J Public Health Date: 2012-06-07 Impact factor: 3.380
Authors: Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel Journal: Circulation Date: 2008-01-22 Impact factor: 29.690
Authors: Barbora Vozarova de Courten; Maximilian de Courten; Robert L Hanson; Alena Zahorakova; Henry P Egyenes; P Antonio Tataranni; Peter H Bennett; Juraj Vozar Journal: Diabetes Res Clin Pract Date: 2003-11 Impact factor: 5.602
Authors: Katarina Rosicova; Andrea Madarasova Geckova; Jitse P van Dijk; Jana Kollarova; Martin Rosic; Johan W Groothoff Journal: Int J Public Health Date: 2010-10-26 Impact factor: 3.380
Authors: Adriana Sudzinova; Jaroslav Rosenberger; Roy E Stewart; Jitse P van Dijk; Sijmen A Reijneveld Journal: Int J Public Health Date: 2015-12-12 Impact factor: 3.380
Authors: Gabriel Kolvek; Ludmila Podracka; Jaroslav Rosenberger; Roy E Stewart; Jitse P van Dijk; Sijmen A Reijneveld Journal: Int J Public Health Date: 2014-10-01 Impact factor: 3.380
Authors: Barbora Silarova; Jitse P van Dijk; Iveta Nagyova; Jaroslav Rosenberger; Sijmen A Reijneveld Journal: Int J Public Health Date: 2013-07-11 Impact factor: 3.380
Authors: Andrej Belak; Andrea Madarasova Geckova; Jitse P van Dijk; Sijmen A Reijneveld Journal: BMC Public Health Date: 2017-01-28 Impact factor: 3.295
Authors: Noha El-Baz; Daniela Ondusova; Martin Studencan; Jaroslav Rosenberger; Sijmen A Reijneveld; Jitse P van Dijk; Berrie Middel Journal: Eur J Cardiovasc Nurs Date: 2017-12-12 Impact factor: 3.908
Authors: Gabriel Kolvek; Zuzana Straussova; Maria Majernikova; Jaroslav Rosenberger; Jitse P van Dijk Journal: Int J Environ Res Public Health Date: 2018-02-18 Impact factor: 3.390
Authors: Ferenc Vincze; Anett Földvári; Anita Pálinkás; Valéria Sipos; Eszter Anna Janka; Róza Ádány; János Sándor Journal: Int J Environ Res Public Health Date: 2019-09-26 Impact factor: 3.390
Authors: János Sándor; Anita Pálinkás; Ferenc Vincze; Nóra Kovács; Valéria Sipos; László Kőrösi; Zsófia Falusi; László Pál; Gergely Fürjes; Magor Papp; Róza Ádány Journal: Int J Environ Res Public Health Date: 2018-08-24 Impact factor: 3.390